| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| FON_NAZ - Bandi Altre Fondazioni |
All-optical fingerprinting of metastatic potential (5° anno)
|
|
Ongoing | 2023 |
| INTLI - Finanziamenti internazionali |
The lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Identification of molecular immune-metabolic profiles in pancreatic cancer to advance management of pancreatic diseases (3° anno)
|
|
Ongoing | 2023 |
| PSR_LINEA2_ / Piano di sviluppo di ricerca - Dotazioni dipartimentali - Linea 2 |
Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2021)
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
The interplay between HPCAL4 and MeCP2: identification and characterization of a novel putative target for Rett syndrome therapy
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Metastasis AS Mechanodisease - 4° anno
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Dissecting the molecular mechanism linking GCase-dependent lysosomal impairment with Parkinson’s disease
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Exploiting innate lymphoid cells to predict clinical progression and response to therapy in myelodysplastic syndromes (1° anno)
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
The link between metabolism and epigenetics in myocardial diseases
|
|
Ongoing | 2022 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Fluoxetine reveres cognitive defects in a mouse model of AT: a preclinical study to elucidate the precise mechanism of action
|
|
Ongoing | 2022 |
